A2 Biotherapeutics: Funding, Investors & Team (Oct 2026)
A2 Biotherapeutics specializes in T cell therapies that accurately differentiate between solid tumors and healthy cells, using the Tmod™ platform to combine various signals for more effective treatment with less harm to normal tissue.
A2 Biotherapeutics has raised $142M across 3 funding rounds on record, the most recent an undisclosed round of $300k announced in May 2025.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
A2 Biotherapeutics Company Profile and Key Stats
Latest funding round on record: May 2025.
A2 Biotherapeutics Funding Rounds
A2 Biotherapeutics raised $62.0M in a Series B announced in Dec 2022.
2.1 years later, a Series C of $80.0M was announced in Jan 2025.
4 months later, an undisclosed round of $300k was announced in May 2025.
A2 Biotherapeutics Founders and Leadership Team
Contact details for the A2 Biotherapeutics team: 2 of 2 have an email address on file.
Start 14-day free trial →A2 Biotherapeutics Funding Compared to Other Biotechnology Startups
A2 Biotherapeutics' latest round of $300k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like A2 Biotherapeutics in Biotechnology and Agoura Hills
Companies Similar to A2 Biotherapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
A2 Biotherapeutics Funding FAQs
What does A2 Biotherapeutics do?
A2 Biotherapeutics specializes in T cell therapies that accurately differentiate between solid tumors and healthy cells, using the Tmod™ platform to combine various signals for more effective treatment with less harm to normal tissue.
How much funding has A2 Biotherapeutics raised?
A2 Biotherapeutics has raised $142M across 3 rounds on record. The most recent is an undisclosed round of $300k announced in May 2025.
When did A2 Biotherapeutics last raise funding?
A2 Biotherapeutics' most recent funding round on record is an undisclosed round of $300k, announced in May 2025.
Who founded A2 Biotherapeutics?
FundedIQ lists Alexander Kamb (Founder) at A2 Biotherapeutics.
Who is the CEO of A2 Biotherapeutics?
Shae L is listed as CEO at A2 Biotherapeutics.
Where is A2 Biotherapeutics headquartered?
A2 Biotherapeutics is based in Agoura Hills, California, United States.
How many employees does A2 Biotherapeutics have?
A2 Biotherapeutics is in the 101-250 employee band.
How does A2 Biotherapeutics' funding compare to other Biotechnology startups?
A2 Biotherapeutics' latest round of $300k is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's A2 Biotherapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for A2 Biotherapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.